Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
BRAIN
Publication-derived

Idiopathic Parkinson's Disease Midbrain Organoids (BN-DS-20)

Source Chlebanowska et al., 2020 · Jagiellonian University Medical College, Faculty of Medicine, Institute of Pediatrics, Department of Transplantation, Kraków, Poland · DOI

Duration: 60 days Cell source: Patient-Derived iPSC (Idiopathic Parkinson's Disease), Human iPSC Full SOP · 7 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain 2D Cell Cultures (BN-DS-20)

Source Doi et al., 2020 · Center for iPS Cell Research and Application, Kyoto University · DOI

Duration: 60 days Cell source: Patient-Derived iPSC (Parkinson's disease) Full SOP · 12 phases · QC included
Drug screening
BN-DS-20 Full SOP with Academic or a plan
LUNG
Publication-derived

Airway Organoids for Infection and Disease Modelling (AW-DS-18)

Source van der Sanden et al., 2018 · Academic Medical Center, Amsterdam · DOI

Duration: 28 days Cell source: Human airway basal stem cells Full SOP · 9 phases · QC included
Disease modelling
AW-DS-18 Full SOP with Academic or a plan
BRAIN
Publication-derived

High-Grade Glioma Brain Organoids (BN-CA-25)

Source Tripathy et al., 2025 · University of Michigan, Department of Neurosurgery · DOI

Duration: 28 days Cell source: Patient-Derived High-Grade Glioma (IDH-wildtype, IDH-mutant, H3K27M-mutant) Full SOP · 7 phases · QC included
Drug screening
BN-CA-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Drug Screening and Disease Modelling

Duration: 66 days Cell source: Human iPSC Full SOP · 7 phases · QC included
Drug screening
Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Cystic Fibrosis Intestinal Organoids for Drug Screening (IN-DS-13)

Source Dekkers et al., 2013 · Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands · DOI

Duration: 24 days Cell source: Primary human intestinal epithelial cells (healthy controls and patients with cystic fibrosis); mouse intestinal crypts Full SOP · 7 phases · QC included
Drug screening
IN-DS-13 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Disease Modelling (No. 2)

Source Yamaguchi et al. · Institute of Science Tokyo (Science Tokyo); The University of Osaka

Duration: 72 days Cell source: Human iPSC (HLA-A, HLA-B, CIITA triple knockout) Full SOP · 10 phases · QC included
Disease modelling
Full SOP with Academic or a plan
BRAIN
Publication-derived

Frontotemporal Dementia Brain Organoids with Astrocytes (BN-DS-23)

Source de Majo et al., 2023 · University of California San Francisco · DOI

Duration: 30 days Cell source: Human iPSC (isogenic wild-type and GRN knockout lines) Full SOP · 9 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
SKIN
Publication-derived

Recessive Dystrophic Epidermolysis Bullosa Epidermal Organ-on-Chip Models (SK-DS-25)

Source Garriga-Cerda et al., 2025 · Columbia University Medical Center · DOI

Duration: 45 days Cell source: Patient-Derived iPSC (RDEB), Wild-type iPSC Full SOP · 8 phases · QC included
Disease modelling
SK-DS-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Schizophrenia Brain Organoids

Source Stachowiak et al.

Duration: 20 days Cell source: Human ESC (H9, HUES8) and Patient-Derived iPSC (Control and Schizophrenia) Full SOP · 7 phases · QC included
Disease modelling
Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organoids for Drug Screening (LV-DS-24)

Source Bronsard et al., 2024 · INSERM, Université de Rennes, INRAE, Institut NuMeCan UMR1317 · DOI

Duration: 14 days Cell source: Human iPSC-derived HepaRG cells, Primary Human Macrophages, LX-2 hepatic stellate cells Full SOP · 6 phases · QC included
Drug screening
LV-DS-24 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Regenerative Medicine (2018) (LV-TX-18)

Source Peng et al., 2018 · Howard Hughes Medical Institute, Department of Developmental Biology, Stanford University School of Medicine · DOI

Duration: 240 days Cell source: Primary mouse hepatocytes (C57BL/6J) Full SOP · 7 phases · QC included
Regenerative medicine
LV-TX-18 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Small Intestinal Bioprinted and Engineered Tissues for Disease Modelling (IN-DS-17)

Source Schlieve et al., 2017 · The Saban Research Institute at Children's Hospital Los Angeles · DOI

Duration: 105 days Cell source: Human iPSC, Human ESC Full SOP · 9 phases · QC included
Disease modelling
IN-DS-17 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening with Vasculature (LV-DS-21)

Source Tsang et al., 2021 · MOE Key Laboratory for Regenerative Medicine, School of Biomedical Sciences, Chinese University of Hong Kong · DOI

Duration: 21 days Cell source: Human iPSC Full SOP · 8 phases · QC included
Drug screening
LV-DS-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Alzheimer's Disease Cerebral Organoids (2018) (BN-DS-18)

Source Gonzalez et al., 2018 · University of Texas Medical School at Houston, Department of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders · DOI

Duration: 110 days Cell source: Human iPSC (familial Alzheimer's disease and Down syndrome patient-derived; healthy control iPSC) Full SOP · 6 phases · QC included
Disease modelling
BN-DS-18 Full SOP with Academic or a plan
LIVER
Publication-derived

Drug-Induced Liver Injury Organoids (LV-IF-25)

Source Soussi et al., 2025 · Cincinnati Children's Hospital Medical Center · DOI

Duration: 72 days Cell source: Patient-Derived iPSC (HLA-B*57:01) Full SOP · 15 phases · QC included
Drug screening
LV-IF-25 Full SOP with Academic or a plan
PANCREAS
Publication-derived

Pancreatic Ductal Adenocarcinoma Organoids (PN-DS-17)

Source Roe et al., 2017 · Cold Spring Harbor Laboratory · DOI

Duration: 360 days Cell source: Patient-Derived iPSC (Pancreatic Ductal Adenocarcinoma) Full SOP · 12 phases · QC included
Disease modelling
PN-DS-17 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Disease Modelling and Long-Term Culture (RT-DS-17)

Source Wahlin et al., 2017 · Wilmer Eye Institute, Johns Hopkins University · DOI

Duration: 300 days Cell source: Human iPSC (IMR90.4, EP1), Human ESC (H7) Full SOP · 3 phases · QC included
Disease modelling
RT-DS-17 Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organoids (2024) (LV-DS-24)

Source Hammour et al., 2024 · Eberhard Karls University, Department of Traumatology, Siegfried Weller Institute, BG Clinic Tübingen · DOI

Duration: 35 days Cell source: Human iPSC-derived HepaRG cells, LX-2 stellate cells, Human HUVEC Full SOP · 10 phases · QC included
Disease modelling
LV-DS-24 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Disease and Development (LV-DS-21)

Source Gamboa et al., 2021 · Rutgers Cancer Institute of New Jersey, Rutgers University · DOI

Duration: 28 days Cell source: Human primary hepatocytes (adult donor-derived) and HepG2 cells Full SOP · 7 phases · QC included
Disease modelling
LV-DS-21 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatocellular Carcinoma Liver Tumouroids (LV-DS-25)

Source Wong et al., 2025 · The Chinese University of Hong Kong, Department of Surgery · DOI

Duration: 24 days Cell source: Patient-Derived iPSC (Hepatocellular Carcinoma) Full SOP · 10 phases · QC included
Drug screening
LV-DS-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Cortical Organoids for Disease Modelling (No. 3)

Duration: 70 days Cell source: Human iPSC Full SOP · 15 phases · QC included
Disease modelling
Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Cystic Fibrosis Intestinal Organoids with Gene Editing (IN-DS-13)

Source Schwank et al., 2013 · Hubrecht Institute/KNAW and University Medical Center Utrecht · DOI

Duration: 30 days Cell source: Patient-Derived iPSC (Cystic Fibrosis) Full SOP · 7 phases · QC included
Disease modelling
IN-DS-13 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Embryo Models for Drug Screening (BN-DS-20)

Source Durens et al., 2020 · Hussman Institute for Autism, University of Maryland School of Medicine · DOI

Duration: 60 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Drug screening
BN-DS-20 Full SOP with Academic or a plan